Department of Health and Human Services
HHS Logo Bottom
HHS Yellow Bar

REMARKS BY:

TOMMY G. THOMPSON, SECRETARY OF HEALTH AND HUMAN SERVICES

PLACE:

Secretary Thompson’s Remarks at the Bio-Defense Press Conference

DATE:

April 28, 2004

Bio-Defense Press Conference

Good morning. I’d like to thank everyone for coming out here today. I’m pleased to be joined by two very distinguished members of this Administration—our Secretary of Homeland Security, Tom Ridge, and Deputy Defense Secretary Paul Wolfowitz.

We’re here today to discuss an issue of the highest importance—protecting our country from the threats of bioterrorism. As you all know, our highest priority is to safeguard the American people. This is a responsibility that President Bush takes seriously, and I know this is a responsibility that each of us here takes very seriously as well.

One of the fundamental requirements of a good plan of action for biodefense preparedness is that we in the Federal government coordinate closely with one another. And we have a good plan in place. Our government is working together in critical ways. What you see before you today is a great example of the collaboration that goes on among the Departments every single day.

So with that said, I’m pleased to introduce Secretary Tom Ridge, my friend and colleague. Secretary Ridge is committed to protecting our Nation, and he is doing a fantastic job. Mr. Secretary…

[Secretary Ridge speaks]

Thank you, Mr. Secretary. I’m honored to work with you in this absolutely vital endeavor. And I’m proud to talk about my Department’s important role in defending America.

It’s important to note how much HHS has accomplished over the past few years, in contributing to our homeland security. The contrast between what we were doing a few years ago and what we are doing today is striking.

HHS spends 12 times as much on bioterror preparedness as we did three years ago. Funding has gone from $305 million in 2001 to $3.9 billion in 2004, and we have requested $4.1 billion for next year. On bioterrorism-related research alone, we’ve gone from spending $53 million in 2001 to $1.6 billion in 2004. That’s more than 30 times as much for bioterrorism research.

HHS has almost ten times as many staff members working on bioterrorism readiness as we did in 2001– we’ve gone from 212 to 1,700 this year.

In order to protect the safety and security of America’s food supplies, we’ve increased food import inspections from 12,000 in 2001 to 60,000 in 2004. And we went from only a few states and regions having coordinated public health and hospital plans in 2001 to having every single state complete joint planning this year.

We’ve dramatically improved our capacity to respond to the threat of smallpox. In 2001, we had only 15 million doses of smallpox vaccine available. Today, we have more than enough doses to vaccinate every man, woman, and child in America, if necessary. Research is also underway toward an improved anthrax vaccine, and we expect it to be available beginning in the middle of 2005.

To build on these successes the President proposed the Project BioShield initiative, to create a more secure source of funding to purchase new vaccines or treatments. $5.6 billion has already been appropriated for BioShield over the next 10 years.

Because of all of these dramatic steps, I am happy to report that we are better prepared to prevent and respond to any public health emergency. But there’s always more we can do. And as Secretary Ridge said, this strategic plan identifies specific areas where we can do more to protect America.

HHS will take the lead on several different elements of this plan.

First, we will anticipate future threats. We know that terrorists want to do everything they can to harm America, and they could be creative in their use of new or different biological agents. We are working to stay a step ahead of those who would harm us—we are using biotechnology, medical research, and other methods to evaluate new toxins and agents that could require new detection methods, preventive measures, and treatments.

Second, HHS will coordinate the development of medical countermeasures. This, of course, ties in closely with our goal of anticipating future threats. We are working to develop safe, effective medical countermeasures against biological weapons agents. And we’re taking into consideration the possibility of new or genetically-engineered agents. We are working to be ready for a wide variety of toxins from across the biological spectrum. This is no small task—but the great scientific minds at the Centers for Disease Control and Prevention, the National Institutes of Health, and the Food and Drug Administration, among other HHS agencies, are up to the challenge.

Lastly, we will continue to lead the effort to prepare for mass casualty care. Our public health system has to be prepared to deal with widespread illness and casualties in the event of a biological attack or a naturally occurring outbreak of disease.

Thankfully, our public health infrastructure is better than ever —from county health departments, to CDC in Atlanta, to the 24-hour command center next to my office that some of you toured this morning. Thanks to our improved infrastructure, we are better able to identify and track outbreaks quickly, putting our resources in quick contact with those who need them.

We know that hospitals, state health departments, and other front-line agencies cannot possibly be fully prepared for any disaster. So we have established Strategic National Stockpiles of pharmaceuticals and medical supplies as part of a nationwide preparedness training and education program for state and local health care providers, first responders, and governments.

These stockpiles include large quantities of antibiotics, chemical antidotes, antitoxins, life-support medications, IV administration, airway maintenance supplies, and medical and surgical items. And we have organized them for a flexible response – we have put together caches of supplies designed to be delivered rapidly when the threat may still be ill-defined.

We call these Push-Packages, and they are stationed in strategically located, secure warehouses ready for immediate deployment. These supplies can be delivered to anywhere in the U.S. or in U.S. territories within twelve hours. We can follow up on the Push-Packages with additional supplies tailored to the event within 24 to 36 hours.

But again, we can do more, and we’re working to strengthen and refine this process. Specifically, we’re working to create a national surge capacity, so that hospitals and Federal, state, local, and private agencies can provide rapidly expandable mass casualty care.

Let me reiterate—the stakes here could not be any higher. We are committed. We are resolved. And we’re ready to do our part to help prepare and protect the country.

Now, I’d like to introduce our Deputy Secretary of Defense, Paul Wolfowitz. Secretary Wolfowitz will talk about the efforts he is helping to coordinate at the Department of Defense.

[Wolfowitz speaks]

Thank you, Secretary Wolfowitz. And now we’re happy to take some questions.

Last Revised: April 29, 2004

HHS Home | Questions? | Contact HHS | Site Map | Accessibility | Privacy Policy | Freedom of Information Act | Disclaimers

The White House | FirstGov